76%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
76%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
76%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
76%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
OrthoPediatrics Corp
Closed
SectorHealthcare
21.97 -2.7
Overview
Share price change
24h
Min
21.87
Max
22.34
Income | 5.4M -11M |
|---|---|
Sales | -256K 52M |
Profit margin | -20.337 |
Employees | 562 |
EBITDA | 156K -11M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +56.75% upside |
Next Earnings | 4 Aug 2025 |
|---|
Market Cap | 21M 545M |
|---|---|
Previous open | 24.67 |
Previous close | 21.97 |
News Sentiment
By Acuity
2%
98%
1 / 376 Healthcare
Technical Score
By Trading Central
Confidence
Strong Bullish Evidence
OrthoPediatrics Corp Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
OrthoPediatrics Corp Forecast
Price Target
By TipRanks
56.75% upside
12 Months Forecast
Average 34.5 USD 56.75%
High 42 USD
Low 26 USD
Based on 6 Wall Street analysts offering 12 month price targets forOrthoPediatrics Corp - Dist in the last 3 months.
Sentiment
By Acuity
1 / 376 Healthcare
News Sentiment
Very Strong Bullish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About OrthoPediatrics Corp
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.
